Member Info for philg65

You a trader Skint?

Still trying to understand how the likes of QBT can be up so much more than ARB....they're not even generating any BTC!

Now you is talking s h i t e!

Benny, dare I say, any positive news to really pump the price will keep the fake accounts from appearing again.

GTC.....sounds like JAdam!!!

It better get back to £3.60 if BTC hits $100k, or accusations of manipulation will spring to mind!

According to Plan B....most definitely.

ARB will be over £3.

Plan B has been bang on with his predictions. He predicts $63k end of Oct and $135 by end of Dec. What price for ARB by then??!!!!

We know that there is a massive disconnect between fair value and growth opportunities, but generally the results are good.

My concern is about the Glycotest and they're not exactly being transparent about these technical difficulties....the market doesn't like uncertainty:

Glycotest (64% holding): Focused on the development of liver cancer diagnostics. Enrolment and progress in the clinical trial continued, building up valuable samples, data and productive sites. The HCC Panel clinical validation study and algorithm training set was delayed by technical issues, which are being progressively worked through.

It's fud, and bear in mind that it was issued just ahead of the today's end of month BTC futures expiration.

It's pure manipulation.

Swag and Twat a tag team of some sort.......I do believe if it becomes like a common cold/Flu, this is still a danger to alot of people and as the virus mutates (and it will), then still need testing!!!!

Mr I, I feel a tad more confident in CK than the t w a t running Genedrive. It is frustrating waiting for FDA/EUA approval , CE Marking and the DHSC contract, but I do believe they will come to imminent fruition.

I think you'll get your money back and a shed load more.

Have to agree with Davemc, the II's probably dictated to DB that if you want our dosh, then give us a 40% discount. Once all the money has been accumulated (assuming that it will), then the MM's will let the price shoot up and allow the II's to make a very healthy buck.

Guess who will be holding those shares once sold!!! DB and the board seriously need to rein in their costs (i.e Salaries) and start to run a business by marketing the a r s e out of it's product portfolio.

Twatcher is the LSE.....dare I say, he regulates posts!!!!

DB will keep his job, regardless. He's more bent than Graham Norton!

The Sales will have to be tens of millions over the next 12-18 months, and I can't see that happening. Looks like a bottom draw hold for this promising share.

It's always seems to be a "nearly" deal with Budd. We supposed to have a deal with a European country some time ago....still waiting.

Now in this RNS, DB states:

"directed towards two near-term revenue opportunities being the final development of the Genedrive(R) COV19 ID Kit, a point of care assay for the detection of SARS-COV-2 ("GDR COV POC") and supporting the commercial roll out of the Company's Antibiotic Induced Hearing Loss test, Genedrive(R) MT-RNR1 ID Kit ("AIHL test") as well as providing additional funding to cover the Group's other product development, commercialisation and general corporate costs until the AIHL test and GDR COV POC are expected to be able to support the Group's overheads."

Best bet is not to take up the offer and they don't receive enough funds....mind you, that will probably be more damaging as Budd has orchestrated this with very fishy hands!!!

More likely to pay for Budd's £400K annual salary!!!

Dare I say it but Budd, you need to go and think an EGM to kick him and the board out needs to be expedited.

Excuse the double post...twitchy fingers!!!